Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and Dermatitis, Atopic

9,10-dimethyl-1,2-benzanthracene has been researched along with Dermatitis, Atopic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cipolat, S; Hoste, E; Natsuga, K; Quist, SR; Watt, FM1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Dermatitis, Atopic

ArticleYear
Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility.
    eLife, 2014, May-05, Volume: 3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma, Squamous Cell; Cell Communication; Cell Differentiation; Cell Transformation, Neoplastic; Cytokines; Dermatitis, Atopic; Disease Models, Animal; Epidermis; Keratinocytes; Membrane Proteins; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; NK Cell Lectin-Like Receptor Subfamily K; Papilloma; Permeability; Plakins; Protein Precursors; Signal Transduction; Skin Neoplasms; Tetradecanoylphorbol Acetate; Thymic Stromal Lymphopoietin; Time Factors

2014